Fatty15 (C15:0 / Pentadecanoic Acid)
Odd-chain saturated fatty acid supplement targeting cellular health, metabolism, and longevity pathways
Bottom Line
Fatty15 is built around pentadecanoic acid (C15:0), an odd-chain saturated fatty acid that the company claims is a newly discovered essential fatty acid. The science is genuinely interesting: cell-based studies show C15:0 activates AMPK, inhibits mTOR, and shares activity profiles with longevity drugs like rapamycin.
The observational data is compelling - higher C15:0 levels are consistently associated with lower rates of type 2 diabetes, heart disease, and metabolic conditions across multiple population studies. People in longevity zones like Sardinia have significantly higher C15:0 levels.
The catches:
- Only 2 human RCTs published, with modest results
- Most research is by the company founder
- "Essential fatty acid" status not recognized by National Academies
- No human longevity trials exist
- CSPI (Center for Science in the Public Interest) is skeptical
An intriguing longevity-focused supplement with plausible mechanisms and interesting observational data, but human trial evidence is early-stage. At $49/month, it's a reasonable bet for longevity enthusiasts willing to be early adopters. Not yet proven enough for mainstream recommendation.
Science
What is C15:0?
Pentadecanoic acid (C15:0) is an odd-chain saturated fatty acid found primarily in: - Dairy fat (butter, whole milk, cheese) - Some fish - Certain plants
Unlike common saturated fats (C16:0, C18:0), C15:0 has an odd number of carbons, giving it different biological properties.
Discovery Story:
C15:0 was identified by Dr. Stephanie Venn-Watson while studying aging in Navy dolphins. Dolphins with higher C15:0 levels had better metabolic health and fewer age-related conditions.
Proposed Mechanisms:
1. Longevity Pathway Activation:
| Pathway | Effect | Significance |
|---|---|---|
| AMPK activation | ↑ | Energy sensing, autophagy |
| mTOR inhibition | ↓ | Matches caloric restriction effects |
| PPARα/δ agonist | ↑ | Metabolic regulation |
These pathways are the same ones targeted by longevity drugs like rapamycin and metformin.
2. Cell Membrane Integration:
- Incorporates into cell membranes
- May improve membrane stability
- Supports mitochondrial function
3. Anti-inflammatory Effects:
- Reduces MCP-1, TNF-α, IL-10
- Comparable to rapamycin in cell studies
Key Research:
Cell-Based Studies (Favorable):
- Venn-Watson 2023: C15:0 matched rapamycin in 24/36 cell-based activities including anti-inflammatory and anticancer effects
Observational Studies (Consistent):
- Higher C15:0 → lower type 2 diabetes risk
- Higher C15:0 → lower cardiovascular disease
- Higher C15:0 → lower NAFLD/NASH
- Sardinian longevity zone: Higher C15:0 levels
Human RCTs (Limited):
- TANGO Trial 2024: 300mg C15:0 + Mediterranean diet modestly reduced LDL in women with NAFLD, but not significantly better than diet alone (except for LDL)
- 2024 Overweight/Obesity Trial: Showed plasma C15:0 increases with supplementation
The "Essential" Debate:
Fatty15 claims C15:0 is essential (must come from diet). The criteria: - Not synthesized in sufficient quantities endogenously ✓ - Required for physiological health - unclear
The National Academies of Science does not recognize C15:0 as essential. A 2024 review called it a "potential candidate" needing more research.
Supporting Studies
4 peer-reviewed studies
View all studies & compare research →Practical Protocol
Standard Dosing:
| Goal | Dose | Duration |
|---|---|---|
| General | 100 mg/day | Ongoing |
| Therapeutic | 200-300 mg/day | 12+ weeks |
Fatty15 Product:
- 100 mg pure C15:0 per capsule
- Recommended: 1 capsule daily
- Vegan (synthesized, not from dairy)
Timing:
- No specific timing required
- With or without food
- Consistency matters more than timing
Natural Sources (Alternative):
| Food | C15:0 Content |
|---|---|
| Butter | ~1% of fat |
| Whole milk | ~1% of fat |
| Full-fat cheese | ~1% of fat |
| Some fish | Variable |
To get 100mg C15:0 from butter, you'd need ~10g of butter - but you'd also get saturated fat, calories, and other compounds.
What to Expect:
- Week 1-4: Plasma C15:0 levels increase
- Week 4-12: Potential biomarker improvements
- Long-term: Theoretical cellular/longevity benefits (unproven)
Combining Approaches:
Some may choose to: - Include moderate whole-fat dairy in diet - Supplement with Fatty15 for precise dosing - Focus on overall Mediterranean-style eating
Risks & Side Effects
Safety Profile:
C15:0 has achieved GRAS (Generally Recognized As Safe) status and has been well-tolerated in clinical trials.
Known Side Effects:
- None significant reported in trials
- Theoretical: Any saturated fatty acid concerns (but C15:0 differs metabolically)
Contraindications:
- None established
- Dairy allergy: Not a concern (Fatty15 is synthetic)
- Pregnancy/nursing: Insufficient data
Concerns:
- Limited human data: Only 2 RCTs published
- Company-funded research: Most studies by founder
- "Essential" claim disputed: Not recognized by major bodies
- Longevity unproven: No human longevity trials
Drug Interactions:
- None documented
- Theoretically could interact with lipid-modifying drugs
- Consult doctor if on statins or other medications
Risk Level: Low (as a supplement), but uncertainty about benefits is high
Who It's For
Most Likely to Try:
- Longevity enthusiasts and early adopters
- Biohackers interested in emerging science
- Those avoiding dairy who want C15:0 benefits
- People focused on metabolic health
- Supplement experimenters with budget
Might Consider:
- Those with metabolic syndrome (experimental)
- People interested in AMPK/mTOR modulation
- Anyone curious about odd-chain fatty acids
Probably Should Skip:
- Those wanting proven interventions only
- Budget-conscious (better proven options exist)
- Those already eating whole-fat dairy regularly
- Skeptics of early-stage supplements
Better Proven Alternatives:
- Creatine - Decades of research, proven benefits
- Mediterranean diet - Proven metabolic benefits
How to Track Results
What to Track:
- Subjective energy and wellbeing
- Metabolic markers (if testing)
- Any noticeable changes
Blood Markers (If Testing):
| Marker | Relevance |
|---|---|
| C15:0 levels | Direct measure (specialized test) |
| LDL cholesterol | May modestly decrease |
| Triglycerides | May improve |
| Fasting glucose | Metabolic health |
| HbA1c | Long-term glucose |
| Liver enzymes (ALT, AST) | Liver health |
| hsCRP | Inflammation |
Realistic Expectations:
- Most people won't "feel" anything
- Benefits are theoretical/cellular
- Biomarker changes may be modest
- Longevity effects unmeasurable in short term
Timeline:
- Plasma C15:0: Increases within 2-4 weeks
- Biomarkers: May change at 8-12 weeks
- Longevity: Impossible to measure personally
Top Products
The Only Brand:
- Fatty15 - The original and only C15:0 supplement
- 100 mg pure FA15 (synthetic C15:0)
- Vegan, no dairy
- GRAS certified
- $49/month
Why Only One Brand:
Fatty15 holds patents on using C15:0 for specific health purposes. They're the only company currently marketing a pure C15:0 supplement.
Natural Alternatives:
If you prefer food sources: - Full-fat dairy (butter, cheese, whole milk) - Grass-fed dairy may have slightly higher C15:0 - But you'd need significant dairy intake for equivalent dose
What to Know:
- Fatty15 is synthetic (not extracted from dairy)
- This allows vegan formulation
- Purity is controlled and consistent
- Company controls all research (potential bias)
Cost Breakdown
Fatty15 Pricing:
| Plan | Price | Per Day |
|---|---|---|
| Monthly | $49 | $1.63 |
| 3-month | $129 | $1.43 |
| Subscription | ~$44/mo | $1.47 |
Cost-Benefit Consideration:
At $49/month, this is mid-range for a specialty supplement. However: - Evidence is early-stage - Better-proven supplements cost less - Dairy fat provides C15:0 naturally (but with other compounds)
Comparison:
| Supplement | Monthly Cost | Evidence Level |
|---|---|---|
| Fatty15 | $49 | C (Preliminary) |
| Creatine | $10-15 | A (Strong) |
Value Assessment:
Only worth it if you: - Have budget for experimental supplements - Value being on the longevity frontier - Understand the evidence limitations
Recommended Reading
- Lifespan: Why We Age, and Why We Don't Have To View →
Who to Follow
Founder/Researcher:
- Stephanie Venn-Watson, DVM, MPH - Co-founder of Fatty15, discovered C15:0 benefits in Navy dolphin research. Lead author on most C15:0 studies. Obvious conflict of interest but legitimate scientific credentials.
Longevity Connection:
- Research parallels interest from longevity researchers in AMPK activation and mTOR inhibition
- David Sinclair's work on NAD+ and sirtuins overlaps conceptually
Skeptics:
- CSPI (Center for Science in the Public Interest) - Published skeptical review questioning the evidence and "essential" claims
Media Coverage:
- Featured in nutritional and longevity media
- Growing awareness but still niche
Synergies & Conflicts
Longevity Stack (Theoretical):
- Fatty15 (C15:0) - AMPK activation
- Creatine - Proven, cellular energy
- NAD+ precursors (NMN/NR) - Sirtuin activation
Metabolic Health Stack:
- Fatty15 (if budget allows)
- Zone 2 Cardio - Proven metabolic benefits
- Time-Restricted Eating - AMPK activation
- Mediterranean diet - Proven cardiometabolic benefits
What Fatty15 Might Complement:
- Low-fat diets (replacing dairy C15:0)
- Vegan diets (no dairy C15:0)
- Longevity-focused regimens
Priority Consideration:
If budget is limited, prioritize proven interventions: 1. Exercise (Zone 2, strength training) - Free 2. Sleep optimization - Free 3. Creatine - $10-15/month 4. THEN consider Fatty15 - $49/month
What People Say
Why It's Getting Attention:
Amazon Reviews:
Common Experiences:
Criticisms:
Reality Check:
This is an early-adopter supplement. Most users won't have objective evidence it's helping. Appeal is to those who want to be ahead of the curve on longevity science.